← Back to Clinical Trials
Recruiting NCT06583616

NCT06583616 The Prognostic Value of Anion Gap in Predicting Mortality Among Patients With Acute Pulmonary Embolism

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06583616
Status Recruiting
Phase
Sponsor Universitas Diponegoro
Condition Acute Pulmonary Embolism (PE)
Study Type OBSERVATIONAL
Enrollment 20 participants
Start Date 2023-01-01
Primary Completion 2024-08-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type OBSERVATIONAL
Interventions
Anion Gap

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20 participants in total. It began in 2023-01-01 with a primary completion date of 2024-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the prognostic value of the anion gap in predicting mortality among patients with acute pulmonary embolism. Researchers will collect information based on hospital registry as secondary data of in patient who had diagnosed as acute pulmonary embolism by using computed tomography scan (CT scan). The data consist of demographic data, clinical presentation, laboratory, and CT scan were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.

Eligibility Criteria

Inclusion Criteria: * age: 18 - 70 years old * patient with acute pulmonary embolism Exclusion Criteria -- patient with history of: * heart failure * valvular heart disease * chronic obstructive pulmonary disease * congenital heart disease * sepsis * chronic kidney disease

Contact & Investigator

Central Contact

Leo Deddy Pradipta, MD

✉ dancingdeagle@gmail.com

📞 +6281316499074

Frequently Asked Questions

Who can join the NCT06583616 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Acute Pulmonary Embolism (PE). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06583616 currently recruiting?

Yes, NCT06583616 is actively recruiting participants. Contact the research team at dancingdeagle@gmail.com for enrollment information.

Where is the NCT06583616 trial being conducted?

This trial is being conducted at Semarang, Indonesia.

Who is sponsoring the NCT06583616 clinical trial?

NCT06583616 is sponsored by Universitas Diponegoro. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology